POST-TRAUMATIC headache predominantly mirrors migraine, but standard therapies frequently fail to provide adequate clinical relief. A recent cross-sectional investigation evaluating 218 adults recovering from mild traumatic brain injury demonstrates that secondary headaches frequently mimic primary headache disorders. Investigators assessed patients presenting two to four months after head trauma with moderate to severe post-traumatic headache and high concussion symptom burdens. The results show that persistent head pain reflects distinct neurobiological phenotypes requiring targeted clinical approaches rather than generic pain protocols.
The study established that 88% of patients exhibited a migraine-like or probable migraine-like phenotype, with migraine without aura representing the single largest category at 38%. Phenotypic distributions remained virtually identical between individuals with acute presentations lasting under three months and those with persistent symptoms extending beyond three months. Furthermore, sex did not influence clinical phenotype presentation. Despite the overwhelming predominance of migraine traits, 85% of patients described a pressing or tightening sensation, and 89% reported bilateral distribution, frequently co-occurring with classic throbbing or unilateral discomfort. High symptom frequency compounded this burden, as 78% experienced at least 15 headache days monthly, and 94% suffered moderate to severe pain intensity.
Therapeutic patterns revealed stark discrepancies between clinical guidelines and actual patient management. Although 88% had used non-opioid analgesics, more than half derived negligible therapeutic benefit. Alarmingly, 27% met criteria for probable medication overuse headache, driven primarily by frequent consumption of over-the-counter analgesics. Conversely, evidence-based acute migraine treatments remained substantially neglected. Clinicians prescribed triptans to only 4% of participants, despite 75% of those recipients achieving positive clinical responses. Preventive pharmacotherapies were equally scarce, prescribed to just 7% of individuals, where they exhibited minimal efficacy across beta-blockers, anticonvulsants, and antidepressants. Non-pharmacological modalities proved similarly disappointing; while half of all participants sought physical therapy, two-thirds reported no meaningful benefit. These findings highlight an urgent need for clinicians managing post-traumatic headache to initiate timely, phenotype-specific interventions while proactively screening for medication overuse.
Reference
Nygaard C et al. Post-traumatic headache two to four months after mild traumatic brain injury: A description of phenotypes and treatment patterns. Cephalalgia. 2026;46(3):1-16.
Featured Image: goodluz on Adobe Stock.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
